Table 3.
Baseline characteristics associated with control of NCD
| Base line characteristic | Controlled NCD N(%) | p value | |
|---|---|---|---|
| Age category | |||
| < 40 | 16 (19.8) | ||
| 40–50 | 38 (46.9) | ||
| > 50 | 27 (33.3) | 0.974 | |
| Sex | |||
| Male | 25 (30.9) | ||
| Female | 56 (69.1) | 0.072 | |
| NCD | |||
| DM only | 2 (2.5) | ||
| HTN only | 74 (91.4) | ||
| HTN and DM | 5 (6.2) | 0.430 | |
| BMI | |||
| < 18.5 | 0 (0) | ||
| 18.5–< 25 | 9 (20.9) | ||
| 25–< 30 | 9 (20.9 | 0.654 | |
| > 30 | 25 (58.1) | ||
| WHO stage | |||
| 0 | 25 (30.9) | ||
| 1 | 21 (25.9) | ||
| 2 | 26 (32.1) | ||
| 3 | 3 (3.7) | ||
| 4 | 6 (7.4) | 0.012 | |
| CD4 count category | |||
| < 350 | 35 (61.4) | ||
| > 350 | 22 (38.6) | 0.404 | |
| Duration on ART | |||
| 0–5 | 59 (72.8) | ||
| 6–10 | 22 (27.2) | ||
| > 10 | 0 (0) | 0.486 | |
| Duration with HIV | |||
| 0–5 | 37 (58.7) | ||
| 6–10 | 18 (28.6) | ||
| > 10 | 8 (12.7) | 0.537 | |
| Duration with NCD | |||
| 0–5 | 36 (72) | ||
| 6–10 | 13 (26.0) | ||
| > 10 | 1 (2.0) | 0.004 | |
| Good adherence | |||
| No | 4 (4.94) | ||
| Yes | 77 (95.1) | 0.204 | |
| Facility | |||
| A | 33 (40.7) | ||
| B | 48 (59.6) | 0.004 | |
Bold p values indicated statitistical significance